BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28057845)

  • 1. Targeting the Epithelial-to-Mesenchymal Transition: The Case for Differentiation-Based Therapy.
    Pattabiraman DR; Weinberg RA
    Cold Spring Harb Symp Quant Biol; 2016; 81():11-19. PubMed ID: 28057845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer.
    Garg M
    Cancer Metastasis Rev; 2015 Dec; 34(4):691-701. PubMed ID: 26328525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of EMT and MET in cancer dissemination.
    Banyard J; Bielenberg DR
    Connect Tissue Res; 2015; 56(5):403-13. PubMed ID: 26291767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epithelial-Mesenchymal Plasticity: A Central Regulator of Cancer Progression.
    Ye X; Weinberg RA
    Trends Cell Biol; 2015 Nov; 25(11):675-686. PubMed ID: 26437589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition in tumor progression.
    Prieto-García E; Díaz-García CV; García-Ruiz I; Agulló-Ortuño MT
    Med Oncol; 2017 Jul; 34(7):122. PubMed ID: 28560682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
    Lu W; Kang Y
    Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
    Mitra A; Mishra L; Li S
    Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
    Katsuno Y; Lamouille S; Derynck R
    Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity: Clonal cooperation in epithelial-to-mesenchymal transition and metastasis.
    Neelakantan D; Drasin DJ; Ford HL
    Cell Adh Migr; 2015; 9(4):265-76. PubMed ID: 25482627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
    Mittal V
    Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets.
    Sato R; Semba T; Saya H; Arima Y
    Stem Cells; 2016 Aug; 34(8):1997-2007. PubMed ID: 27251010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapies.
    Hollier BG; Evans K; Mani SA
    J Mammary Gland Biol Neoplasia; 2009 Mar; 14(1):29-43. PubMed ID: 19242781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target.
    Jonckheere S; Adams J; De Groote D; Campbell K; Berx G; Goossens S
    Cells Tissues Organs; 2022; 211(2):157-182. PubMed ID: 33401271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
    Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
    Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular signature and therapeutic perspective of the epithelial-to-mesenchymal transitions in epithelial cancers.
    Sabbah M; Emami S; Redeuilh G; Julien S; Prévost G; Zimber A; Ouelaa R; Bracke M; De Wever O; Gespach C
    Drug Resist Updat; 2008; 11(4-5):123-51. PubMed ID: 18718806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma.
    Jayachandran A; Dhungel B; Steel JC
    J Hematol Oncol; 2016 Aug; 9(1):74. PubMed ID: 27578206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EMT universe: space between cancer cell dissemination and metastasis initiation.
    Ombrato L; Malanchi I
    Crit Rev Oncog; 2014; 19(5):349-61. PubMed ID: 25404150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.
    Zhang Y; Weinberg RA
    Front Med; 2018 Aug; 12(4):361-373. PubMed ID: 30043221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach.
    Turner C; Kohandel M
    J Theor Biol; 2010 Aug; 265(3):329-35. PubMed ID: 20648969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy.
    Franco-Chuaire ML; Magda Carolina SC; Chuaire-Noack L
    Invest Clin; 2013 Jun; 54(2):186-205. PubMed ID: 23947008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.